OPS
SMMT icon

Orion Portfolio Solutions’s Summit Therapeutics SMMT Stock Holding History

Orion Portfolio Solutions’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$443K Buy
22,970
+12,141
+112% +$244K ﹤0.01% 1470
2024
Q4 		$193K Buy
+10,829
New +$210K ﹤0.01% 1758

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Orion Portfolio Solutions's SMMT Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Summit Therapeutics (SMMT) stake by 112% in Q1 2025, buying an estimated $244K and bringing the position to 22,970 shares worth $443K. The position accounts for ﹤0.01% of the portfolio, ranked #1470.

Orion Portfolio Solutions first reported a position in SMMT in Q4 2024 and has held it in 2 quarters since. 212 funds tracked by Wall St. Rank hold SMMT as of Q1 2025.

  • Orion Portfolio Solutions held 22,970 shares of Summit Therapeutics worth $443K as of Q1 2025.
  • Orion Portfolio Solutions bought 12,141 Summit Therapeutics shares in Q1 2025, an estimated $244K.
  • Summit Therapeutics made up ﹤0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1470 holding.
  • Orion Portfolio Solutions first reported a position in Summit Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 212 funds tracked by Wall St. Rank held Summit Therapeutics as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.